Skip to main content
logo
Enveric Biosciences, Inc. (ENVB)
NASDAQ: ENVB · Real-Time Price · USD
1.535
+0.025 (1.66%)
At close: Aug 14, 2026, 4:00 PM EDT
1.610
+0.075 (4.89%)
After-hours: Aug 14, 2026, 7:53 PM EDT

Enveric Biosciences Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Selling, General & Admin
5.685.796.458.8511.7319.88
Research & Development
2.382.782.847.257.914.76
Operating Expenses
8.228.779.6316.4519.9625.29
Operating Income
-8.22-8.77-9.63-16.45-19.96-25.29
Interest Expense
-0-0---0.01-0.01
Interest & Investment Income
--00--
Other Non Operating Income (Expenses)
000.07-0.827.468.2
EBT Excluding Unusual Items
-8.22-8.77-9.57-17.26-12.5-17.1
Merger & Restructuring Charges
------0.65
Impairment of Goodwill
-----1.49-8.23
Asset Writedown
-----5.97-30.45
Pretax Income
-8.22-8.77-9.57-17.26-19.96-56.43
Income Tax Expense
--0.010.03-1.49-7.45
Net Income
-8.22-8.77-9.57-17.29-18.47-48.98
Preferred Dividends & Other Adjustments
3.363.36-0.170.33-
Net Income to Common
-11.58-12.13-9.57-17.46-18.8-48.98
Net Income Growth
------
Shares Outstanding (Basic)
1000--
Shares Outstanding (Diluted)
1000--
Shares Change
814.40%698.70%249.38%---
EPS (Basic)
-17.16-36.24-228.48-1455.50--
EPS (Diluted)
-17.16-36.24-228.48-1455.50--
EPS Growth
------

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-8.01-8.14-7.73-14.1-17.73-11.65
Free Cash Flow Per Share
-11.86-24.32-184.36-1175.46--
EBITDA
-8.06-8.57-9.29-16.1-19.63-24.64
D&A For EBITDA
0.160.20.340.340.330.66
EBIT
-8.22-8.77-9.63-16.45-19.96-25.29
SEC Filings: 10-K · 10-Q